Resectable Pancreatic Cancers
2 clinical trials · Condition
◉ Watch Resectable Pancreatic Cancers
| Record | Firm | Date |
|---|---|---|
| Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer (NCT02318095) | Duke University | 2015-02-17 |
Track Resectable Pancreatic Cancers automatically
Every clearance here is in the API, with alerts when new ones post.